Live News Categoriesequity

Harvard Bioscience, Inc. (HBIO) News

Follow Harvard Bioscience, Inc. (HBIO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol HBIO Asset equity Sector Markets 90 days 1 Last 8.37 Updated Aug 11, 2026, 11:05 AM UTC Open live news feed Open HBIO chart & news

L Harvard Bioscience Sees FY2026 Sales $89.147M-$90.877M vs $88.600M Est. Harvard Bioscience (NASDAQ: HBIO ) sees FY2026 sales of $89.147 million-$90.877 million vs $88.600 million analyst estimate. Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth. EARNINGS | Aug 11, 2026, 11:05 AM UTC